On July 13, the Food and Drug Administration approved the first over-the-counter birth control pill, Opill. It’s expected to become available in the first quarter of 2024, and people will be able to purchase it online and at pharmacies, convenience stores, and grocery stores without a prescription (STAT News, July 13; Inside Health Policy, July 14).
On July 13, CMS proposed a 1.25% pay cut for doctors under the Medicare physician fee schedule for 2024. Under the rule, CMS aims to revise quality reporting and financial benchmarking requirements under the Medicare Shared Savings Program; increase access to behavioral health services; and finally expand a model for treating Medicare patients with diabetes in underserved communities. Comments on the proposed rule are due by September 11 and the final rule is expected later this fall (Modern Healthcare, July 14; PoliticoPro, July 13).
On July 13, CMS proposed Medicare CY 2024 payment rates for hospital outpatient and Ambulatory Surgery Center services along with many other proposed policies to align with the goals of the Biden administration to promote health equity, expand access to behavioral health care, improve transparency in the health system, and address medical product shortages. The comment period will end on September 11 with the final rule anticipated for the fall (CMS, July 13).
From July 12 through July 19, CMS approved two Appendix K waivers and 13 SPAs, six of which are COVID-19 disaster relief SPAs.